Lab Management
Beckman Coulter, Inc. announced today the completion of the acquisition of Olympus' lab-based diagnostics business.
| 2 min read
Biotech was "hot" in July driven by drug data, positive drug sales/earnings and partnering and M&A deals. As a result, the Burrill Biotech Select Index posted a solid monthly gain of 6.5 percent
| 3 min read
Though digital technologies and high-speed communications have significantly expanded the capabilities of scientists, these technologies are also raising difficult questions for researchers, institutions, and journals.
| 2 min read
Agilent Technologies Inc. and Varian Inc. today announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a leading worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications.
| 3 min read
Los Alamos National Laboratory has received $212 million for environmental cleanup activities under the American Recovery and Reinvestment Act.
| 1 min read
Alberta, Canada will be home to a new research and product development center and state-of-the-art Hitachi microscopes.
| 3 min read
See how a university team helped this lab manager improve the efficiency of his testing environment, which led to more satisfied customers, monetary savings, and less overtime for lab staff.
| 5+ min read
Academic labs attract stimulus money but funding challenges remain
| 5+ min read
From the seas to the stars, Microsoft Research is trying to increase its impact. The Redmond, WA-based computer science research organization is releasing new software tools aimed at helping scientists manage and visualize huge amounts of information.
| 3 min read
In the future, Europe will not play a significant role in the world if it is not a powerhouse for scientific and technological advances
| 2 min read
June employment data from the Department of Labor show that job losses in the chemical sector have accelerated during 2009. Preliminary numbers indicate that the industry employs 41,300 fewer workers than at the same time a year earlier
| 2 min read
With key patents worth a projected $30 billion in revenue pegged to expire between 2010 and 2013, pharmaceutical companies are looking for ways to improve the effectiveness and efficiency of their drug discovery and development programs.
| 5+ min read
